Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Mitaka
Clinical trial register · Japan

Clinical Trials in Mitaka, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Fukuoka 551 Nagoya 517 Sapporo 398 Tokyo 369 Osaka 348
Narrow the registerReset
Recruitment status
Phase
Site location
Fukuoka551 Nagoya517 Sapporo398 Tokyo369 Osaka348
All 926 locations
Target enrolment
to

Trials with a site in Mitaka

19 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
348
Kawasaki, Kobe, Kodaira-shi, Maebashi, Minatoku, Mitaka, Nagasaki, Sapporo
2026-07-23
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Bunkyō City, Hamamatsu, Higashi-Ibaraki, Kagoshima, Kashiwa, Kumamoto, Minatoku, Mitaka
2026-05-23
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Asahikawa, Bunkyō City, Fujiidera, Fukuoka, Hirosaki, Kagoshima, Kashiwa, Mitaka
2026-03-26
Recruiting
Eli Lilly and Company
Phase 3
1,980
Adachi-ku, Chūōku, Fukuoka, Minato, Mitaka, Suita-shi, Tokyo
2026-02-06
Recruiting
Pfizer
Phase 3
140
Sendai, Niigata, Osaka, Hamamatsu, Mitaka
2025-09-10
Recruiting
Boston Scientific Corporation
Not applicable
1,616
Sapporo, Sagamihara, Mitaka, Kochi
2025-08-21
Active, closed
Pfizer
Phase 3
208
Sendai, Niigata, Hamamatsu, Mitaka, Osaka
2025-07-31
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Fukuoka, Hyōgo, Ibaraki, Kamakura, Meguro City, Mitaka, Miyagi, Toyota
2025-05-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Nagoya, Suita, Bunkyo, Mitaka, Fukuoka, Okayama
2025-05-12
Recruiting
Pfizer
Phase 3
674
Kurume, Sendai, Niigata, Hamamatsu, Koto-ku, Mitaka, Shinjuku-ku, Osaka
2025-04-01
Recruiting
NovoCure GmbH
Phase 3
741
Toyoake-shi, Isehara, Fukuoka, Hokkaido, Ishikawa, Kumamoto, Kyoto, Mitaka
2025-02-03
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Bunkyō City, Fukuoka, Mitaka, Nagoya, Okayama, Shinjuku-Ku, Suita
2024-09-03
Active, closed
Takeda
Phase 2
213
Sakura, Sapporo, Hirakata, Minato, Minato-ku, Mitaka, Fukuoka, Saga
2024-03-29
Recruiting
Haihe Biopharma Co., Ltd.
Phase 1/2
141
Sapporo, Kobe, Yokohama, Sendai, Matsumoto, Mitaka, Gifu
2023-08-22
Recruiting
Eli Lilly and Company
Phase 3
595
Hamamatsu, Kurume, Mitaka, Miyagi-gun, Niigata, Osaka, Shinjuku-ku, Ube
2023-02-27
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NCT05325034Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia
Stephen Nicholls
Not applicable
2,000
Fukuoka, Mitaka, Osaka
2022-09-15
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Shinjuku-ku, Fukuoka, Itabashi-ku, Kumamoto, Mitaka, Miyazaki, Sendai, Tsu
2022-06-30
Active, closed
Savara Inc.
Phase 3
164
Chiba, Sapporo, Yokohama, Kumamoto, Sendai, Sakai, Saitama, Mitaka
2021-05-19
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
Nagoya, Kitakyushu, Sendai, Miyazaki, Mitaka, Shinjuku, tabashi City, Kitakyushu-shi
2020-07-01
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/mitaka

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Mitaka.

How many clinical trials are recruiting in Mitaka?

13 of the 19 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mitaka), 19 studies
PhaseStudiesRecruitingShare
Phase 312863.2%
Phase 23115.8%
Not applicable2210.5%
Phase 1/2115.3%
Phase 2/3115.3%

Most active sponsors

Lead sponsors with the most studies (Mitaka)
Lead sponsorStudiesRecruiting
Eli Lilly and Company33
Pfizer32
Janssen Research & Development, LLC22
Sun Pharmaceutical Industries Limited20
Boston Scientific Corporation11
Corxel Pharmaceuticals11
Gossamer Bio USA, Inc.11
Haihe Biopharma Co., Ltd.11
Merck Sharp & Dohme LLC10
NovoCure GmbH11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.